STEPHANIE DE SANTIAGO: Open Payments
NPI 1497303028 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 18 payments from 14 companies in 2025. Trend: 2023 $42 · 2024 $0 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $59 |
| Eisai Inc. | 2 | $45 |
| Biogen, Inc. | 2 | $42 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| C2N Diagnostics, LLC | 2 | $28 |
| ARGENX US, INC. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: Leqembi, TYSABRI, Fintepla, EPIDIOLEX, PRECIVITYAD2, VYVGART HYTRULO, REXULTI, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
